2006N-0062
  

  
Expanded Access to Investigational Drugs for Treatment Use
  


  

  

  


  

  
FDA Comment Number : 
  

  
EC53
  



  

  
Submitter : 
  

  
Mrs. Colleen Mockbee
  

  
Date & Time: 
  

  
03/13/2007 06:03:23
  



  

  
Organization : 
  

  
Eli Lilly
  



  

  
Category : 
  

  
Drug Industry
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 See Attachment



  


  

  


  

  



  

  
2006N-0062-EC53-Attach-1.PDF